http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2015071882-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ed28726de9f916f355f8adc331e736b8
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2770-36141
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2770-36143
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-5256
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-572
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-0011
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-86
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-001182
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-001188
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K48-0058
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K48-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-86
filingDate 2014-09-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_24f8536f8a210a6bc474c79f5f321648
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c9d3f067c50d5cf67571ca7591efdd94
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_357b0f31be2be61ae72cc281bf49495e
publicationDate 2015-03-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-2015071882-A1
titleOfInvention Method for inducing antitumor immunity using sindbis viral vectors and tumor associated antigens
abstract The subject application is directed to a method for treating a mammal harboring a tumor comprising identifying a tumor associated antigen (TAA) expressed by the tumor and parenterally administering to the mammal a therapeutically effective amount of a Sindbis viral vector carrying a gene encoding the TAA to the mammal sufficient to elicit an immune response directed against the tumor, and thereby treating the tumor.
priorityDate 2013-09-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2014294765-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004102410-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID46783367
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5280965
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226408030
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226408029
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226408028
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID656652
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID50990393
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID439530
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396546
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396589
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127796639
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID53782688

Total number of triples: 40.